Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study
暂无分享,去创建一个
Ning Ma | Rui Wang | Yiming Tian | Yang He | Lianyuan Liu | Huili Li | Rui Shi | Bohua Zhang | Ningning Lin
[1] Ş. Keşkek,et al. Direct medical cost of nephropathy in patients with type 2 diabetes , 2021, International Urology and Nephrology.
[2] G. Zuccotti,et al. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease. , 2021, Metabolism: clinical and experimental.
[3] S. Wen,et al. Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis , 2021, Frontiers in Immunology.
[4] Tetsuhiro Tanaka,et al. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan , 2020, BMJ Open Diabetes Research & Care.
[5] Fang Li,et al. The Antagonist of CXCR1 and CXCR2 Protects db/db mice from Metabolic Diseases through Modulating Inflammation. , 2019, American journal of physiology. Endocrinology and metabolism.
[6] P. Matusz,et al. Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients. , 2019, Journal of diabetes and its complications.
[7] M. Chattopadhyay,et al. Early Urinary Markers for Diabetic and Other Kidney Diseases. , 2018, Current drug targets.
[8] Shu-Yan Liu,et al. Clinical significance of serum interleukin‐8 and soluble tumor necrosis factor‐like weak inducer of apoptosis levels in patients with diabetic nephropathy , 2018, Journal of diabetes investigation.
[9] Wei Duan,et al. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study , 2017, BMC Nephrology.
[10] R. MacIsaac,et al. The impact of hyperfiltration on the diabetic kidney. , 2015, Diabetes & metabolism.
[11] J. Bouchard,et al. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. , 2013, Diabetes research and clinical practice.
[12] M. Muraguchi,et al. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy. , 2009, Journal of diabetes and its complications.
[13] P. Bacchetti,et al. Sample size calculations in clinical research. , 2002, Anesthesiology.
[14] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[15] C. Mogensen,et al. The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy , 1983, Diabetes.
[16] L. Gnudi,et al. Diabetic Nephropathy: An Overview. , 2020, Methods in molecular biology.
[17] No Authors. Standards of Medical Care in Diabetes — 2021 , 2022, KIDNEYS.